Stay updated on Switching to Cabotegravir and Rilpivirine: Clinical Trial
Sign up to get notified when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.

Latest updates to the Switching to Cabotegravir and Rilpivirine: Clinical Trial page
- CheckyesterdayChange DetectedThe site’s revision tag was updated from v3.6.4 to v3.6.5, reflecting a new release version of the software or page framework.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4. This signals a new software release rather than changes to the study details or page content.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedAdded two new study locations: Ciudad Autonoma Buenos Aires, Argentina, C1405CKC and Guadajalara, Mexico, 44280. Removed previously listed Ciudad Autonoma de Bueno, Argentina, C1405CKC and Guadalajara, Mexico, 44280, indicating a replacement/update of site entries.SummaryDifference0.1%

- Check36 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3.SummaryDifference0.0%

- Check43 days agoChange DetectedAdded a new revision entry v3.6.2 and removed the previous v3.6.0 from the page's revision history. This indicates an incremental update to the page version.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now indicates recruitment has ceased and adds new guidance sections to help readers understand the study record and how to join, alongside a minor header/label update and revision tag.SummaryDifference0.2%

Stay in the know with updates to Switching to Cabotegravir and Rilpivirine: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.